Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
HBK Master Fund LP - Form 8.3 - Warner Chilcott Plc PR Newswire London, July 31 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
HBK Master Fund LP - Form 8.3 - Warner Chilcott Plc PR Newswire London, July 30 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
HBK Master Fund LP - Form 8.3 - Warner Chilcott Plc PR Newswire London, July 29 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
DUBLIN/LONDON (dpa-AFX) - In der Pharmabranche bahnt sich offenbar die nächste Milliardenübernahme an. Das irische Unternehmen Warner Chilcott hat nach Informationen der Nachrichtenagentur...
ARDEE, Ireland, Dec. 15 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) today announced that its subsidiary Warner Chilcott Corporation (the "Company") has commenced a cash tender...
ARDEE, Ireland, Nov. 19 /PRNewswire/ -- Warner Chilcott plc (NASDAQ:WCRX) today announced the pricing of its previously announced secondary offering of 20,000,000 of its ordinary shares at a...
ARDEE, Ireland, Oct. 30 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) announced today it has completed the acquisition of The Procter & Gamble Company's global branded prescription...
ARDEE, Ireland and COPENHAGEN, Sept. 23 /PRNewswire-FirstCall/ -- Warner Chilcott plc (NASDAQ:WCRX) and LEO Pharma announced today that, in exchange for a one-time cash payment of $1.0 billion...
NEW YORK (dpa-AFX) - Jefferies hat Aktien von Warner Chilcott <WCRX.NAS> nach dem Kauf der Arzneimittelsparte von Procter & G<PG.NY<PRG.FSE>S> von "Hold" auf "Buy" hochgestuft. Das...
ARDEE, Ireland, Aug. 21 /PRNewswire-FirstCall/ -- Warner Chilcott (NASDAQ: WCRX) announced today that its redomestication has been completed and the ultimate public holding company of the Warner...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
